Fundz

Medical robotics startup MedInTech raises KRW 33.8 billion in Series C funding led by Atinum Investment and KB Investment to expand AI robotic endoscope production.

PRIVATENov 16, 2026

Amount Raised

₩33.8 Billion

Round Type

Series C

South KoreaBiotechnologyHealth CareArtificial IntelligenceMedical Device

Investors

K2 Investment PartnersWooshin Venture InvestmentIcfSL InvestmentSmilegate InvestmentKB InvestmentAtinum Investment

Description

MedInTech, a medical robotics startup, has closed a Series C funding round of KRW 33.8 billion, jointly led by Atinum Investment and KB Investment. The company's cumulative funding now reaches KRW 62.2 billion. Existing investors including Smilegate Investment, SL Investment, ICF (Nextrance), and Wooshin Venture Investment participated, with K2 Investment Partners joining as a new investor. The capital will support expansion of domestic and overseas supply of AI robotic endoscopes and entry into treatment and surgical robotics markets.

Quick answer

MedInTech raised ₩33.8 Billion in a Series C round, dated November 16, 2026. Investors: K2 Investment Partners, Wooshin Venture Investment, Icf, SL Investment, Smilegate Investment, KB Investment and Atinum Investment. MedInTech is based in South Korea.

How much did MedInTech raise?
MedInTech raised ₩33.8 Billion in a Series C round on November 16, 2026.
Who invested in MedInTech?
K2 Investment Partners, Wooshin Venture Investment, Icf, SL Investment, Smilegate Investment, KB Investment and Atinum Investment are named as investors in this round.
What does MedInTech do?
MedInTech Inc. is a South Korea's medical smart endoscopes startup founded in 2020 by CEO Lee Chi-won and Vice President Kim Myung-joon, with a focus on developing an electric endoscope that is more intuitive and 50%..
Where is MedInTech based and how big is it?
MedInTech is based in South Korea.
Who are the decision-makers at MedInTech?
Fundz holds 1 contact at MedInTech. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical Device and Biotechnology around the same time

Companies in the same sectors as MedInTech that raised within 45 days of this round, from Fundz verified event records.

  • TestDynamics raised $9M (Series A) on November 16, 2026.
  • Boston Medical Sciences raised $35M (Series B) on November 13, 2026.
  • Kardi Ai raised $5.9M (Series A) on November 11, 2026.
  • Mosaic Intelligence Labs raised $47M (Seed) on November 10, 2026.
  • Laza Medical raised $160M (Series B) on November 4, 2026.
  • Impress raised $45M (Debt Financing) on October 27, 2026.

Who to call at MedInTech, and when

A new round usually means MedInTech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MedInTech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MedInTech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MedInTech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MedInTech

Location

South Korea

About

MedInTech Inc. is a South Korea's medical smart endoscopes startup founded in 2020 by CEO Lee Chi-won and Vice President Kim Myung-joon, with a focus on developing an electric endoscope that is more intuitive and 50% lighter than conventional endoscopes, leveraging medical robot technology. The company also possesses anomaly detection software based on artificial intelligence to enhance physician convenience and reduce misdiagnosis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MedInTech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for MedInTech's next move

See what Strategic adds

MedInTech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.